Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis - PubMed (original) (raw)
Review
Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis
David J A Jenkins et al. CMAJ. 2008.
Abstract
Background: A recent Cochrane meta-analysis did not confirm the benefits of fish and fish oil in the secondary prevention of cardiac death and myocardial infarction. We performed a meta-analysis of randomized controlled trials that examined the effect of fish-oil supplementation on ventricular fibrillation and ventricular tachycardia to determine the overall effect and to assess whether heterogeneity exists between trials.
Methods: We searched electronic databases (MEDLINE, EMBASE, The Cochrane Central Register of Controlled Trials, CINAHL) from inception to May 2007. We included randomized controlled trials of fish-oil supplementation on ventricular fibrillation or ventricular tachycardia in patients with implantable cardioverter defibrillators. The primary outcome was implantable cardioverter defibrillator discharge. We calculated relative risk [RR] for outcomes at 1-year follow-up for each study. We used the DerSimonian and Laird random-effects methods when there was significant heterogeneity between trials and the Mantel-Hanzel fixed-effects method when heterogeneity was negligible.
Results: We identified 3 trials of 1-2 years' duration. These trials included a total of 573 patients who received fish oil and 575 patients who received a control. Meta-analysis of data collected at 1 year showed no overall effect of fish oil on the relative risk of implantable cardioverter defibrillator discharge. There was significant heterogeneity between trials. The second largest study showed a significant benefit of fish oil (relative risk [RR] 0.74, 95% confidence interval [CI] 0.56-0.98). The smallest showed an adverse tendency at 1 year (RR 1.23, 95% CI 0.92-1.65) and significantly worse outcome at 2 years among patients with ventricular tachycardia at study entry (log rank p = 0.007).
Conclusion: These data indicate that there is heterogeneity in the response of patients to fish-oil supplementation. Caution should be used when prescribing fish-oil supplementation for patients with ventricular tachycardia.
Figures
Figure 1: Selection of studies for meta-analysis.
Figure 2: Meta-analysis of implantable cardioverter defibrillator discharge in studies of fish-oil supplementation. Significant heterogeneity was detected between trials (p = 0.04). Note: CI = confidence interval.
Figure 3: Sensitivity analysis of the trials by (A) Leaf et al and Brouwer et al; (B) Raitt et al and Brouwer et al; and (C) Raitt et al and Leaf et al. Significant heterogeneity was detected between the trials by Raitt et al and Leaf et al (p = 0.01). Note: CI = confidence interval. *Number of participants who experienced an implantable cardioverter defibrillator discharge.
Figure 4: Meta-analysis of all-cause mortality in studies of fish-oil supplementation among patients with implantable cardioverter defibrillators. No significant heterogeneity was detected (p = 0.29). Note: CI = confidence interval.
Comment in
- Should patients with cardiovascular disease take fish oil?
Nair GM, Connolly SJ. Nair GM, et al. CMAJ. 2008 Jan 15;178(2):181-2. doi: 10.1503/cmaj.071654. CMAJ. 2008. PMID: 18195293 Free PMC article. Review. No abstract available.
Similar articles
- Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Connolly SJ, et al. Eur Heart J. 2000 Dec;21(24):2071-8. doi: 10.1053/euhj.2000.2476. Eur Heart J. 2000. PMID: 11102258 - Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators.
Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, Katan MB, Connor WE, Camm JA, Schouten EG, McAnulty J. Brouwer IA, et al. Eur Heart J. 2009 Apr;30(7):820-6. doi: 10.1093/eurheartj/ehp003. Epub 2009 Feb 4. Eur Heart J. 2009. PMID: 19196720 Free PMC article. Review. - Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C. Ghanbari H, et al. Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255. Arch Intern Med. 2009. PMID: 19752408 - Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.
Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D; Fatty Acid Antiarrhythmia Trial Investigators. Leaf A, et al. Circulation. 2005 Nov 1;112(18):2762-8. doi: 10.1161/CIRCULATIONAHA.105.549527. Circulation. 2005. PMID: 16267249 Clinical Trial. - Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
Prystowsky EN. Prystowsky EN. Rev Cardiovasc Med. 2001 Fall;2(4):197-205. Rev Cardiovasc Med. 2001. PMID: 12439369 Review.
Cited by
- Omega-3 Index and sudden cardiac death.
Von Schacky C. Von Schacky C. Nutrients. 2010 Mar;2(3):375-388. doi: 10.3390/nu2030375. Epub 2010 Mar 23. Nutrients. 2010. PMID: 22254028 Free PMC article. Review. - Effect of fish oil on arrhythmias and mortality: systematic review.
León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. León H, et al. BMJ. 2008 Dec 23;337:a2931. doi: 10.1136/bmj.a2931. BMJ. 2008. PMID: 19106137 Free PMC article. Review. - N-3 fatty acids for prevention of cardiovascular disease.
Khawaja OA, Gaziano JM, Djoussé L. Khawaja OA, et al. Curr Atheroscler Rep. 2014 Nov;16(11):450. doi: 10.1007/s11883-014-0450-0. Curr Atheroscler Rep. 2014. PMID: 25214423 Review. - The effects of supplementation with omega-3 polyunsaturated Fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? It depends….
Rauch B, Senges J. Rauch B, et al. Front Physiol. 2012 Apr 2;3:57. doi: 10.3389/fphys.2012.00057. eCollection 2012. Front Physiol. 2012. PMID: 22485090 Free PMC article. - Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction.
Smith PJ, Blumenthal JA, Babyak MA, Georgiades A, Sherwood A, Sketch MH Jr, Watkins LL. Smith PJ, et al. Am J Clin Nutr. 2009 May;89(5):1315-20. doi: 10.3945/ajcn.2008.26829. Epub 2009 Mar 25. Am J Clin Nutr. 2009. PMID: 19321564 Free PMC article.
References
- CBC News. Contaminated fish? Benefits outweigh the risks. Toronto: Canadian Broadcasting Corporation; 2007. Available: www.cbc.ca/news/background/foodsafety/fish.html (accessed 2007 Aug 15).
- BBC.co.uk. Guidance on oily fish consumption. London (UK): BBC; 2004. Available: http://news.bbc.co.uk/1/hi/health/3834955.stm (accessed 2007 Aug 15).
- Barton A. How flawed is your fish? Globe and Mail [Toronto] 2007. Available: www.theglobeandmail.com/servlet/story/RTGAM.20070516.wxlfish16/BNStory/G... (accessed 2007 Nov 20).
- Mozaffarian D, Rimm EB. Fish intake, contaminants and human health: evaluating the risks and the benefits. JAMA 2006;296:1885-99. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical